RFP - supply of entecavir and tenofovir disoproxil tablets or capsules
PHARMAC invites proposals for the supply of entecavir and tenofovir disoproxil in New Zealand.
This request for proposals (RFP) document incorporates the following schedules:
- Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
- Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
- Schedule 4 [DOCX, 22 KB] contains the RFP form in which you are to provide details of your proposal.
Full text of RFP - supply of entecavir and tenofovir disoproxil in New Zealand [PDF, 245 KB]
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 4.00 p.m. on 16 August 2017 - RFx 18852797.
If you have any enquiries about this RFP you should submit them via GETS or alternatively contact Chloë Dimock by email firstname.lastname@example.org.
We look forward to receiving your proposal.